Hi Lynda,
lyndacarol wrote:
Dignan – In the opening post of this "Summary of the pipeline" thread, in the pre-clinical grouping you have listed:
70. 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICAR) (Medical University of South Carolina)
I am recently interested in AICAR; can you post more information about this University of South Carolina work? I understand some researchers with HHMI have been doing work on AICAR/exercise/diabetes. Do you know if this drug is available OTC or only by prescription or perhaps only to researchers?
I watched an episode of Nova Science Now a while back (probably around July 2009) that discussed AICAR. The show discussed the work by Ronald M. Evans who was at the Salk Institute. Ronald Evans found that AICAR triggers a change in the gene expression in muscle tissue and causes muscle to produce both larger mitochondria and increased numbers of mitochondria. Both of these effects are identical to the physiological effects of endurance exercise such as running. Essentially, it made "couch potato" mice (those without access to an exercise wheel) perform like "long distance runner" mice (those with access to an exercise wheel).
Here are two websites where you can find out more info about Ronald Evans.
The Salk Institute:
http://www.salk.edu/faculty/evans.htmlHoward Hughes Medical Institute:
http://www.hhmi.org/research/investigat ... s_bio.htmlYou can also find his papers on
PubMed by doing an author search, e.g., "evans rm [au]" though you might find some unrelated work by authors with similar names.
I hope that this is helpful.
For what it's worth, AICAR is available from the chemical supply companies such as
Sigma-Aldrich. However, I don't know if it's available from supplement suppliers in a form fit for human consumption.
By the way, it would be interesting to know what Terry Walhs thinks of this research...
NHE